(Rac)-EC5026 (Synonyms: (Rac)-BPN-19186) |
| Katalog-Nr.GC62743 |
(Rac)-EC5026 ((Rac)-BPN-19186) ist ein potenter Piperidin-Inhibitor der lÖslichen Epoxidhydrolase (sEH), extrahiert aus Patent WO2019156991A1, Seite 39, hat einen Ki von 0,06 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1809885-55-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) extracted from patent WO2019156991A1, page 39, has a Ki of 0.06 nM. (Rac)-EC5026 can be used for the research of Parkinson’s disease and dementia with Lewy Bodies (DLB)[1].
(Rac)-EC5026 inhibits soluble epoxide hydrolase (sEH), with a Ki of 0.06 nM[1].
[1]. Hammock BD, et, al. Methods of inhibiting formation of alpha synuclein aggregates. WO2019156991A1.
Average Rating: 5 (Based on Reviews and 23 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *